Research on CRISPR/system in major cancers and its potential in cancer treatments.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Z LiuH Xiao

Abstract

Cancer is a serious public health problem in the world and the prevention and control of cancer has become one of the health strategies of governments around the world. According to the data of the International Agency for Research on Cancer (IARC), about 8 million people die of cancer every year in the world. With the continuous progress of medical technology, there are many methods to treat cancer at present. However, many treatment methods have achieved different therapeutic effects, some of them have obvious toxic and side effects. Therefore, it is necessary to study simpler and more effective new therapies for alleviating pain and prolonging lifetime of patients. In this view, we focus on the application progress of CRISPR system in some major cancers and its potential in cancer treatments.

References

Mar 9, 2002·Omics : a Journal of Integrative Biology·Rund JansenLeo M Schouls
Apr 16, 2002·Molecular Microbiology·Ruud JansenLeo M Schouls
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Dec 11, 2007·Journal of Bacteriology·Hélène DeveauSylvain Moineau
Jul 2, 2010·Nature Reviews. Cancer·Cary A Moody, Laimonis A Laimins
May 3, 2011·Current Opinion in Microbiology·Michael P Terns, Rebecca M Terns
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Feb 13, 2013·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·S N SotiropoulosC Lenglet
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Zhonggang HouJames A Thomson
May 3, 2014·Seminars in Oncology·Hyeonjoo CheonGeorge R Stark
Jul 22, 2014·Biochemical and Biophysical Research Communications·Shuai ZhenYan Li
Apr 2, 2015·Nature·F Ann RanFeng Zhang
Jun 23, 2015·Nature·Benjamin P KleinstiverJ Keith Joung
Dec 3, 2015·Science·Ian M SlaymakerFeng Zhang
Dec 17, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Benjamin BakondiShaomei Wang
Feb 5, 2016·Cancer Letters·Ting Wu, Yun Dai
Nov 3, 2016·Nature Reviews. Clinical Oncology·Maurizio Zanetti
Jun 3, 2016·Oncotarget·Faheem Ahmed KhanZhang ShuJun
Jun 5, 2016·Analytical Biochemistry·Neville E Sanjana
Dec 17, 2016·Cell Research·Leticia CorralesThomas F Gajewski
Mar 16, 2017·Methods : a Companion to Methods in Enzymology·Alexis Guernet, Luca Grumolato
Apr 15, 2017·Science·Jonathan S GootenbergFeng Zhang
Sep 21, 2017·Nature·Janice S ChenJennifer A Doudna
Oct 3, 2017·Nature Medicine·Rodrigo RomeroThales Papagiannakopoulos
Oct 7, 2017·Cell·Anupama ReddySandeep S Dave
Oct 8, 2017·Genome Biology·Péter István KulcsárErvin Welker
Dec 5, 2017·The Journal of Clinical Investigation·Liying ChenKimberly Stegmaier
Feb 13, 2018·Nature Biotechnology·Antonio CasiniAnna Cereseto

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Related Papers

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Hai Rim Shin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
M Daher
Central European Journal of Public Health
Karolina Krupa-Kotara, Dominika Dakowska
Medicinski pregled
Marica Miladinov-Mikov
© 2021 Meta ULC. All rights reserved